ResMed Corporation (RMD) - Long-Term Liabilities to Capital

Corporate emblem and logo of ResMed Inc. (RMD)

ResMed Inc. (RMD) production facilities in the US, Singapore, and Australia ensure business resilience through stable demand for respiratory therapy devices. The company is expanding its profile by implementing cloud services for remote patient monitoring, which minimizes the risk of price erosion for core devices. Serving as a valuation tool, this chart of long-term liabilities to equity at 0.08 confirms the brand's dominance and high customer loyalty to the AirView ecosystem.

Long-Term Debt to Capital: ResMed Corp (RMD) for 07/04/2022 - 10/30/2026

Analytical breakdowns for ResMed Inc.

- stock price and consensus target price:
Quote Chart ResMed Inc|RMD - Analyst Consensus Forecast
- market capitalization indicators:
Market Value ResMed Inc.|RMD - Enterprise Value
- book value of equity indicators:
Accounting Value per Share ResMed|RMD - Book Capitalization|Market Capitalization to Book Value resmed.com|RMD - Company Total Assets
- debt and solvency information:
Total Debt to Capital ResMed Inc.|RMD - Long-Term Debt to Equity|Short-Term Debt to Equity resmed.com|RMD - Company Aggregate Debts|Debts to Net Assets ResMed Inc.|RMD - Company Long-Term Liabilities|Current Liabilities ResMed|Immediate Liquidity resmed.com
- company profitability and valuation multiples indicators:
RMD - Net Profit
Summary company analysis:ResMed Inc.
Core merchandise of resmed.com

ResMed Inc. (RMD) maintains its leadership in apnea therapy, yet the expansion of GLP-1 drugs and pressure from Medicare tariffs create risks for cash flow stability. The long-term debt-to-equity ratio measures the proportion of borrowed financing exceeding one year, allowing investors to assess financial stability and debt load via this chart of long-term debt to equity.

Competing companies

Boston Scientific Corp - Long-Term Liabilities to Equity|Long-Term Debt to Capital EW|PODD - Long-Term Liabilities to Capital|Long-Term Debt to Capital ZBH (Zimmer Biomet Corp)|COO - Long-Term Debt to Equity Ratio|Align Technology - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Globus Medical Inc GMED|TMDX: Long-Term Debt to Capital|Alphatec Corp (ATEC) - Long-Term Debt to Capital|Long-Term Debt to Equity Artivion, Inc.|Long-Term Debt to Equity ENOV|Long-Term Debt to Capital IART|Ratio of Long-Term Indebtedness to Capital Establishment Labs Corp|Beta Bionics Corp - Long-Term Debt to Equity Ratio|IRMD (IRADIMED Inc.) - Long-Term Liabilities to Equity|Embecta Corp. - Long-Term Debt to Capital|Long-Term Liabilities to Capital tandemdiabetes.com|AXGN: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio SIBN|Long-Term Debt to Equity Ratio OFIX|BVS: Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity OrthoPediatrics Corp. (KIDS)|Long-Term Debt to Equity Ratio treace.com TMCI|Long-Term Debt to Capital SRTA (Strata Critical Medical)|Carlsmed, Inc. (CARL) - Long-Term Liabilities to Capital|RxSight Corp - Long-Term Debt to Capital|CLPT (ClearPoint Neuro, Inc.) - Long-Term Debt to Capital Ratio|STXS: Long-Term Debt to Capital|STIM - Ratio of Long-Term Indebtedness to Capital|SGHT (Sight Sciences) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Orchestra BioMed Inc. (OBIO)|Long-Term Debt to Capital ANIK|Long-Term Debt to Capital InspireMD Inc. (NSPR)|Long-Term Debt to Equity Jin Medical ZJYL|Vivani Medical Inc - Long-Term Debt to Equity|XTNT: Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient NMTC (NeuroOne)|MODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Myomo Inc (MYO)|Long-Term Debt to Equity Envoy Medical, Inc.|VVOS - Long-Term Indebtedness to Equity|Long-Term Debt to Equity Ratio NVNO (enVVeno Medical Corp.)|Long-Term Debt to Capital sintx.com (SINT)|Long-Term Debt to Capital TNON (Tenon Medical, Inc)|Ratio of Long-Term Indebtedness to Capital Lifeward Ltd. (LFWD)|AMIX - Long-Term Debt to Equity|Long-Term Liabilities to Equity IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Axonics Inc.|BIOL (Biolase, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital Dynatronics Corp. DYNT|Long-Term Debt to Equity Paragon 28, Inc. (FNA)|invobioscience.com - Long-Term Debt to Capital Ratio